His

Clinical Drug Information

English NameResearch CodeHighest Development StageCompanyIndicationClinical Trial
Praluzatamab ravtansineCX-2009Phase 2 ClinicalImmunogen Inc, Cytomx Therapeutics IncSolid tumours; Ovarian Neoplasms; Head and Neck Neoplasms; Neoplasms; Triple Negative Breast Neoplasms; Breast Neoplasms; Carcinoma, Non-Small-Cell Lung
Details
  • Product List
  • Clinical Drug Information